Promising biomarkers to select patients for checkpoint inhibitor therapy in melanoma

Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, gives an overview of the use of biomarkers to select patients for checkpoint inhibitor therapy in melanoma at ... Author: VJOncology Added: 02/23/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts